Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanxi Hengruida Pharmaceutical is a Chinese pharmaceutical company focused on the research, development, and manufacturing of finished dosage forms and active pharmaceutical ingredients (APIs). The company operates production lines for various formulations, including tablets, capsules, and granules, covering therapeutic areas such as anti-infectives, cardiovascular health, and digestive system disorders. Based in the Shanxi province, it serves the domestic Chinese market with a range of generic medications and essential drugs. The firm emphasizes quality control and compliance with Good Manufacturing Practice (GMP) standards to maintain its position in the regional healthcare supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanxi Hengruida Pharmaceutical.